Raras
Buscar doenças, sintomas, genes...
Anemia hemolítica autoimune
ORPHA:98375CID-11 · 3A20OMIM 205700DOENÇA RARA

A anemia hemolítica autoimune (AIHA) é uma doença autoimune na qual vários tipos de autoanticorpos são direcionados contra os glóbulos vermelhos, fazendo com que sua sobrevivência seja encurtada e resultando em anemia hemolítica.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A anemia hemolítica autoimune (AIHA) é uma doença autoimune na qual vários tipos de autoanticorpos são direcionados contra os glóbulos vermelhos, fazendo com que sua sobrevivência seja encurtada e resultando em anemia hemolítica.

Pesquisas ativas
34 ensaios
104 total registrados no ClinicalTrials.gov
Publicações científicas
4.180 artigos
Último publicado: 2026 Apr

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
11.0
Denmark
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🩸
Sangue
10 sintomas
🫃
Digestivo
5 sintomas
🫁
Pulmão
3 sintomas
❤️
Coração
2 sintomas
🛡️
Imunológico
1 sintomas
🫘
Rins
1 sintomas

+ 25 sintomas em outras categorias

Características mais comuns

Palidez
Palpitações
Anemia hemolítica
Autoimunidade
Dor nas costas
Taquicardia
49sintomas
Sem dados (49)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 49 características clínicas mais associadas, ordenadas por frequência.

PalidezPallor
PalpitaçõesPalpitations
Anemia hemolíticaHemolytic anemia
AutoimunidadeAutoimmunity
Dor nas costasBack pain

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico4.180PubMed
Últimos 10 anos200publicações
Pico2025150 papers
Linha do tempo
2026Hoje · 2026🧪 1997Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 34
2Fase 24
1Fase 16
·Pré-clínico6
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Anemia hemolítica autoimune

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

16 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

104 ensaios clínicos encontrados, 34 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.701 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.701

#1

Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies.

Blood reviews2026 Mar 12

Autoimmune cytopenias (AICs) arise from pathogenic autoantibody-mediated destruction of blood cells. Current treatments often fail to achieve durable remission, necessitating long-term treatment including immunosuppression and exposure to treatment-related toxicities. Insights into B cell biology demonstrate the central role of autoreactive B cells and plasma cells in sustaining disease activity and relapse, providing a rationale to achieve sustained, treatment-free remissions through "immune reset". This review summarizes the current understanding of immune reset in AICs and examines clinical data for depletion strategies targeting distinct stages of B cell maturation. We compare therapeutic modalities across monoclonal antibodies, bispecific T cell engagers (TCE), and chimeric antigen receptor (CAR) T cells. The depth and breadth of depletion, kinetics of immune reconstitution, and treatment-related risks are critical determinants of long-term outcome potential and individualized risk-benefit assessment. Collectively, these advances support a potential paradigm shift from chronic immunosuppression towards durable remissions off therapy with time-limited therapeutic interventions.

#2

Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials.

Lupus science &amp; medicine2026 Mar 18

To define a clinically meaningful treatment response definition for haemolytic anaemia, that will form part of a novel multidomain outcome measure for SLE clinical trials. An international working group comprising 12 clinicians and 4 patients completed a multistep consensus process. First, the scope of haemolytic anaemia for the SLE clinical trial context was defined. Candidate response measures were then nominated via an online survey and shortlisted for evaluation via a systematic literature review (SLR) focussing on relevant measurement properties and clinical trial utility. Informed by the SLR results, the working group used nominal group technique (NGT) to reach consensus on a response measure, as well as entry, clinically meaningful response and complete response thresholds. The domain scope was unanimously agreed on as 'immune-mediated haemolytic anaemia attributed to active lupus that impacts the patient and is modifiable by therapy to reduce or control disease activity', including Coombs' positive autoimmune haemolytic anaemia and rarer subtypes. Six laboratory measures to fit this scope were shortlisted for the SLR, which screened 1519 articles, of which 10 were included. Consensus via NGT was reached on haemoglobin (Hb) improvement to measure haemolytic anaemia treatment response. Thresholds were defined for entry (Hb <100 g/L with laboratory confirmation of haemolysis), minimum clinically meaningful response (Hb improvement >20 g/L or Hb normalised with ongoing haemolysis) and complete response (Hb normalised without haemolysis). Hb, with meaningful thresholds for entry and improvement, will be adopted to classify haemolytic anaemia treatment response in a novel multi-domain outcome measure for SLE clinical trials.

#3

Autoimmune hemolytic anemia: New frontiers in diagnosis and therapy.

Blood reviews2026 Mar 06

Autoimmune hemolytic anemias comprise warm AIHA (wAIHA), due to IgG autoantibodies reacting at body temperatures, and cold agglutinin disease (CAD), due to IgM reacting in cold and strongly activating complement. The diagnosis, based on the direct antiglobulin test (DAT), is sometimes difficult since the DAT is performed with various methods with different sensitivity and specificity. Novel investigation includes DAT by flow-cytometry that helps the diagnosis of DAT-negative forms and in-deep bone marrow examination that aims to understand AIHA pathogenesis. Therapy is different in wAIHA and CAD: in the former, steroids represent the first-line, followed by rituximab, splenectomy and immunosuppressors, while in the latter rituximab is recommended frontline, followed by rituximab plus chemotherapy or the complement inhibitor sutimlimab. Plasmacell-directed therapies (bortezomib and daratumumab) may be administered in refractory patients. Several new therapies are under investigation, including inhibitors of Bruton's and spleen tyrosine kinases, neonatal Fc receptor, and cytokines, and bi-specific monoclonal antibodies.

#4

Warm autoimmune hemolytic anemia in adults in Latin America: A scoping review.

Hematology, transfusion and cell therapy2026 Mar 07

Autoimmune hemolytic anemia is a rare disorder characterized by the autoimmune-mediated destruction of red blood cells. The condition is classified into subtypes based on the thermal reactivity of the autoantibodies, with warm autoimmune hemolytic anemia representing the most common form in adults. This review aimed to summarize the clinical evidence regarding warm autoimmune hemolytic anemia generated in adult patients within the Latin American region. A literature search was conducted in Embase, Medline, Lilacs, Cochrane Library, Epistemonikos, and Value in Health in April 2023. Gray literature was also consulted. Records were eligible for inclusion if they presented data on the epidemiology, diagnosis, treatment, or healthcare resource utilization among adult warm autoimmune hemolytic anemia patients in Latin American countries. Clinical practice guidelines on the condition issued in Latin American were also eligible. Nine records were included: seven retrospective studies (six single-center), one national clinical guidelines (Mexico), and one therapeutic protocol (Brazil). Corticosteroids are the cornerstone of first-line treatment, reported in 97.7 % of 354 patients enrolled in the studies, primarily as monotherapy (91 %). While response rates were high (69-84 %), a considerable proportion of patients (15-40 %) required second-line therapies. The use of splenectomy varied widely between studies, from being the preferred second-line option to not being performed in any patient. Access barriers contribute to a limited use of rituximab. Compared to other hemolytic disorders, warm autoimmune hemolytic anemia studies are lacking in Latin American and consist primarily of single-center, retrospective case series. Further research is warranted to understand management strategies in refractory disease.

#5

Therapeutic plasma exchange as a rescue and bridging therapy for life-threatening autoimmune hemolytic anemia associated with angioimmunoblastic T-cell lymphoma.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2026 Apr

Autoimmune hemolytic anemia (AIHA) is a potentially life-threatening complication of lymphoid malignancies, and transfusion management can be particularly challenging in refractory cases. We report a case of angioimmunoblastic T-cell lymphoma complicated by severe, transfusion-refractory warm AIHA, in which red blood cell transfusion was paradoxically associated with a hyperhemolysis-like process and overt disseminated intravascular coagulation. Despite corticosteroid therapy and rituximab, repeated transfusions failed to produce sustained hemoglobin increments and were followed by worsening hemolysis and coagulopathy. Detailed immunohematologic evaluation demonstrated panreactive IgG autoantibodies with persistently positive direct antiglobulin testing and elevated polyethylene glycol-enhanced indirect antiglobulin test reactivity. Therapeutic plasma exchange was initiated as a rescue intervention, resulting in a progressive reduction in circulating autoantibody reactivity, restoration of transfusion efficiency, and stabilization of hemoglobin levels, despite persistent direct antiglobulin test positivity. Following effective lymphoma-directed chemotherapy, hemolysis resolved completely, and transfusion independence was achieved. This case highlights post-transfusion deterioration resembling hyperhemolysis in lymphoma-associated AIHA and underscores the potential role of therapeutic plasma exchange as a rescue and bridging therapy in life-threatening, transfusion-refractory disease.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2.422 artigos no totalmostrando 198

2026

Pediatric Evans Syndrome as a Multisystem Immune Disorder: A 13-Year Longitudinal Experience from a Single Academic Center.

Pediatric reports
2026

CD19/CD22-targeted CAR T cells in autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation.

Haematologica
2026

Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies.

Blood reviews
2026

Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials.

Lupus science &amp; medicine
2026

Crohn`s disease, vedolizumab and autoinmmune hemolytic anemia: coincidence or causality?

Revista espanola de enfermedades digestivas
2026

A Complex Case of Anti-e Mimicking Autoantibody Development Leading to Warm Autoimmune Hemolytic Anemia: Case Report.

Acta haematologica
2025

Case Report: jaundice in the young: the complexity of rare diseases beyond cholangiopathies.

Frontiers in gastroenterology (Lausanne, Switzerland)
2026

Mixed Autoimmune Hemolytic Anemia With Refractory Cold Agglutinin Syndrome in a Child Successfully Treated With Serial Whole Blood Exchange Transfusions and Immunosuppression.

Journal of pediatric hematology/oncology
2026

Autoimmune hemolytic anemia: New frontiers in diagnosis and therapy.

Blood reviews
2026

Cephalexin-Induced Autoimmune Hemolytic Anemia: A Case Report.

Cureus
2026

From Hemolysis to Lupus: A Case of Evans Syndrome Revealing Systemic Autoimmunity.

Clinical case reports
2026

Warm autoimmune hemolytic anemia in adults in Latin America: A scoping review.

Hematology, transfusion and cell therapy
2026

Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis.

ACR open rheumatology
2026

A Rare Case of Severe Cold Autoimmune Hemolytic Anemia in a Hemochromatosis Carrier.

Case reports in hematology
2026

A Novel Autoimmune Presentation of Wiskott-Aldrich Syndrome: Type 1 Diabetes.

Immunity, inflammation and disease
2026

Small B-cell lymphoma highly suspicious for splenic marginal zone lymphoma with MYD88 L265P mutation and MYC copy-number gain presenting as severe autoimmune hemolytic anemia: a case report with literature review.

Frontiers in immunology
2026

Therapeutic plasma exchange as a rescue and bridging therapy for life-threatening autoimmune hemolytic anemia associated with angioimmunoblastic T-cell lymphoma.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
2026

When Warm Meets Cold: Mixed-Type Autoimmune Hemolytic Anemia Revealing an Underlying Autoimmune Disorder.

Cureus
2026

Don't neglect the non-thrombotic manifestations of antiphospholipid syndrome in children - autoimmune hemolytic anemia and myocarditis: a case report and literature review.

Frontiers in immunology
2026

Neoadjuvant Pembrolizumab Associated with Chemotherapy in Early Triple-Negative Breast Cancer Patients: Real-World Data from a French Single-Center Experience.

Cancers
2026

High thrombotic burden in severe Chinese wAIHA patients: a single-center retrospective study.

Thrombosis journal
2026

Clinical characterization and targeted genetic mutation profiling of autoimmune disease-associated B-cell lymphoma.

Discover oncology
2025

Cold agglutinin syndrome in a patient with metastatic breast cancer: a Case Report.

Frontiers in medicine
2026

A Rare Autoimmune Hemolytic Overlap: Coombs-Positive Pernicious Anemia.

Cureus
2026

Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein: A Case Report.

Internal medicine (Tokyo, Japan)
2026

Overlapping autoimmunity and immunodeficiency: a case of selective IgA deficiency with autoimmune hemolytic anemia.

BMC pediatrics
2026

Extremely High Levels of Cold Agglutinins in Giant Cell Hepatitis With Autoimmune Hemolytic Anemia.

Pediatric blood &amp; cancer
2026

Transfusion-induced hemolysis in warm autoimmune hemolytic anemia with autoantibodies that have anti-e specificity: a case report and systematic review of the literature.

Therapeutic advances in hematology
2025

Multisystem Complications in Postpartum-Onset Evans Syndrome: A Case Report.

Cureus
2026

Cold clues in pediatric autoimmune hemolytic anemia.

Blood advances
2026

Immune-Mediated Multilineage Cytopenias in Thymoma: A Retrospective Case Series.

Thoracic cancer
2026

Disseminated intravascular coagulation secondary to postpartum hemorrhage complicated with autoimmune hemolytic anemia: A case report.

The Journal of international medical research
2026

Thrombophilia screening in patients with autoimmune hemolytic anemia: a single-center analysis.

Haematologica
2026

Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

Pediatric blood &amp; cancer
2026

Unicentric Castleman Disease as a Sufficient and Reversible Cause of Steroid-Refractory Autoimmune Hemolytic Anemia in a Child.

Pediatric blood &amp; cancer
2026

Potential Role of IFIH1 Gene Variant in Autoimmune Hemolytic Anemia: A Case Report.

Journal of pediatric hematology/oncology
2026

CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia.

The New England journal of medicine
2025

[Advances in the treatment of cold agglutinin disease and their impact on quality of life].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2026

Beyond hemorrhagic pancreatitis: Levofloxacin-induced hemolytic anemia presenting with Grey-Turner sign.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2026

Pediatric Evans Syndrome Diagnostic Evaluation Patterns: Survey Results From the Pediatric ITP Consortium of North America.

Pediatric blood &amp; cancer
2026

Clinical features, treatment and outcomes of pembrolizumab induced autoimmune hemolytic anemia.

Investigational new drugs
2026

Bruton tyrosine kinase inhibitors and invasive aspergillosis and mucormycosis: a case report and multi-center exploratory retrospective study.

ASM case reports
2025

Incidence, Risk Factors, and Treatment of Autoimmune Cytopenia Following Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.

Journal of transplantation
2026

Lyme disease as a rare trigger for autoimmune hemolytic anemia.

BMC infectious diseases
2026

Moyamoya angiopathy associated with autoimmune hemolytic anemia in an Asian-a case report and its long-term follow-up in a resource-limited setting.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Encephalitis and Immune-Related Complications in a Patient Treated With Nivolumab: A Case Report.

Case reports in medicine
2025

Paroxysmal Cold Hemoglobinuria Associated With Monoclonal B-Cell Lymphocytosis in an Elderly Patient: A Report of a Rare Case.

Cureus
2025

Autoimmune Hemolytic Anemia in Non-Hodgkin's Lymphoma: Pathogenesis, Diagnosis, and Management.

Nigerian journal of clinical practice
2025

Positive Indirect Antiglobulin Test in Adult Patients With Primary Warm Autoimmune Hemolytic Anemia: Clinical Significance and Prognostic Effect on Response to Corticosteroids.

Advances in hematology
2025

Double Trouble: The First Reported Case of Evans Syndrome Following RSV Vaccination.

Hematology reports
2026

Mutations in histone lysine methyltransferase genes are associated with autoimmune cytopenias: a single-center study.

Blood vessels, thrombosis &amp; hemostasis
2025

Severe relapse of Evans syndrome in an adult patient with treatment resistance and fatal outcome: A case report.

The Journal of international medical research
2025

Case Report: Severe gastric atrophy associated with a novel homozygous variant in LRBA.

Frontiers in pediatrics
2025

Outcome predictors of systemic lupus erythematosus requiring admission to the intensive care unit.

World journal of critical care medicine
2025

Community-acquired Acinetobacter pneumonia associated with Evans syndrome: a case report.

Annals of medicine and surgery (2012)
2025

Diagnosis and management of cold agglutinin disease.

Hematology. American Society of Hematology. Education Program
2025

Management of autoimmune hemolytic anemia.

Hematology. American Society of Hematology. Education Program
2025

Obinutuzumab in systemic lupus erythematosus: a real-world experience.

Frontiers in immunology
2025

A novel CTLA-4 deletion variant in a child with refractory autoimmune hemolytic anemia: molecular and functional characterization.

Frontiers in immunology
2025

Systemic Lupus Erythematosus With Catastrophic APS and Libman-Sacks Endocarditis in a Patient With Autoimmune Hemolytic Anemia: A Case Report.

Clinical case reports
2025

Unraveling the Complexity: A Case of Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, and Autoimmune Cholangitis.

Cureus
2025

Splenectomy Linking Guillain-Barré Syndrome, Autoimmune Haemolysis, and Epstein-Barr Virus Viraemia: Unveiling a Hidden Diagnosis of Angioimmunoblastic T-cell Lymphoma.

Cureus
2025

Catatonia as the initial manifestation of neuropsychiatric lupus.

Oxford medical case reports
2025

Interleukin-6 accelerates the progression of warm autoimmune hemolytic anemia by affecting the DNA methylation status of peripheral blood B lymphocytes.

Scientific reports
2025

[When AIHA does not explain everything: parvovirus B19 infection and pancytopenia as a differential diagnostic challenge].

Innere Medizin (Heidelberg, Germany)
2026

Eculizumab as an adjunctive rescue treatment for life-threatening childhood onset of systemic lupus erythematosus.

Lupus
2025

A Rare Case of Autoimmune Hemolytic Anemia in Pancreatic Adenocarcinoma.

International journal of hematology-oncology and stem cell research
2025

A Case of Refractory Mycoplasma Pneumonia With Extra-pulmonary Manifestations in a Community-Acquired Setting.

Cureus
2025

Warm Autoimmune Hemolytic Anemia Unmasked by Blood Transfusion in a Patient With Prostate Cancer: A Case Report.

Cureus
2025

Case Report: Severe autoimmune hemolytic anemia in an elderly patient caused by warm-reactive IgG and IgA autoantibodies.

Frontiers in immunology
2025

Diffuse Large B-Cell Lymphoma Combined With Paroxysmal Nocturnal Hemoglobinuria: A Rare Case Report.

Clinical case reports
2025

Life-threatening vancomycin-induced immune hemolytic anemia: A rare case report.

Medicine
2025

A rare case of autoimmune hemolytic anemia with protein S deficiency with splenic infarct.

Asian journal of transfusion science
2025

Timely diagnosis of a case of Paroxysmal Cold Haemoglobinuria using Donath-Landsteiner test.

Asian journal of transfusion science
2025

Safety and efficacy of least incompatible red cell units in autoimmune hemolytic anemia: A prospective analysis of hemoglobin increment and hemolysis after transfusion.

Asian journal of transfusion science
2025

Study of Bone Marrow Findings in Human Immunodeficiency Virus (HIV) Positive Patients in a Tertiary Care Hospital.

Cardiovascular &amp; hematological disorders drug targets
2026

Protracted Febrile Illness and Coma in an Adolescent with Sickle Cell Disease and Malaria.

The American journal of tropical medicine and hygiene
2025

Case Report: Autoimmune hemolytic anemia associated with ovarian teratoma in a 13-year-old: a rare paraneoplastic presentation.

Frontiers in pediatrics
2025

Case Report: Challenges in immunotherapy for the elderly: a case of refractory ICI-induced AIHA and thrombocytopenia in advanced gastric cancer.

Frontiers in immunology
2025

Case Report: Coexisting cold agglutinin disease and acquired hemophilia A: a rituximab-responsive dual autoimmune disorder.

Frontiers in medicine
2025

A Tale of Immune Fragility: Severe Mycoplasma pneumoniae Infection With Mixed Autoimmune Hemolytic Anemia in Selective IgM Deficiency Disorder.

Cureus
2025

An 80-year-old man with a rare disease manifestation of disseminated cryptococcosis.

IDCases
2025

Severe immunotherapy-related autoimmune hemolytic anemia induced by toripalimab in a patient with deficient mismatch repair colorectal cancer: a case report and literature review.

Frontiers in medicine
2025

Hematologic Involvement in Systemic Lupus Erythematosus: Clinical Features and Prognostic Implications in a Hematology-Referred Cohort.

Journal of clinical medicine
2025

[Frontier advances in chimeric antigen receptor T cells and chimeric antigen receptor regulatory T cells therapies for autoimmune diseases].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
2025

Cerebral venous sinus thrombosis with cold agglutinin disease in summer: illustrative case.

Journal of neurosurgery. Case lessons
2025

Successful Treatment of Refractory IgA-Mediated Autoimmune Hemolytic Anemia With Bortezomib.

EJHaem
2025

Nivolumab-Induced Warm Autoimmune Hemolytic Anemia and Pancytopenia.

Cureus
2025

Partial arch replacement for type A aortic dissection with cold agglutinin disease after sutimlimab.

Journal of cardiology cases
2025

Cold versus warm autoimmune hemolytic anemia in diffuse large B cell lymphoma: pathogenic and therapeutic implications: a case series.

Journal of medical case reports
2026

Evidence that mycophenolate mofetil is a safe and effective immunosuppressive in the treatment of autoimmune hepatitis and Evans syndrome: Case report.

International journal of clinical pharmacology and therapeutics
2026

Childhood isolated C3d-positive AIHA: favorable prognosis but rare relapse or associated immunodeficiency.

Blood advances
2025

Iptacopan for cold agglutinin disease: a case report with literature review.

Frontiers in immunology
2025

Mixed Warm and Cold Autoimmune Hemolysis in an Elderly Patient With Sickle Cell Disease and End-Stage Renal Disease on Hemodialysis: A Diagnostic and Therapeutic Challenge.

Cureus
2025

Increased percentages of circulating T follicular helper cells associate with disease subtype and activity in pediatric immune cytopenias.

Haematologica
2025

Autoimmune Hemolytic Anemia Occurring One Year Before Acute Leukemic Manifestation of Lymphoma with a Chronic Lymphocytic Leukemia Immunophenotype.

Internal medicine (Tokyo, Japan)
2026

Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: a propensity score-matched study.

Blood advances
2025

Cryptococcal Meningitis Without Headache: A Case Report Highlighting an Atypical Presentation.

Cureus
2025

Comparison of flow cytometric osmotic fragility test between kinetic and endpoint assay principle.

Cytometry. Part B, Clinical cytometry
2025

Evans Syndrome in a 35-Year-Old Male: Diagnostic Challenges and Multimodal Management.

Cureus
2025

Refractory cold autoimmune hemolytic anemia as initial presentation of gastric B cell lymphoma: a case report.

Journal of medical case reports
2026

Effect of obexelimab on the production of anti-RBC antibodies and cytokines in patients with warm autoimmune hemolytic anemia.

Blood advances
2025

[Autoimmunity in Patients with CTLA-4 Haploinsufficiency].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2025

Cold Agglutinin Syndrome as the Initial Presentation of Acute Myeloid Leukemia: A Case Report.

Clinical case reports
2025

Severe autoimmune hemolytic anemia in ICU: a place for emergency plasma exchange? A French multicenter retrospective study.

Critical care (London, England)
2025

A case report on the treatment of autoimmune hemolytic anemia after CBT by daratumumab in a mucopolysaccharidosis type III patient.

Medicine
2025

Autoimmune cytopenias in inborn errors of immunity: associations with monogenic mutations and immunologic parameters.

BMC immunology
2025

Mediastinal nocardiosis causing dysphagia/odynophagia: a case report.

Indian journal of thoracic and cardiovascular surgery
2026

Pyruvate Kinase Deficiency: An Underdiagnosed Cause of Severe Hemolytic Anemia in Iranian Population: Insights From Whole Exome Sequencing of Four Families and Screening of a Population-Specific Database.

International journal of laboratory hematology
2025

Cryoagglutinin autoimmune hemolytic anemia secondary to Mycoplasma pneumoniae infection in patient with pernicious anemia: A case report.

Medwave
2025

Long-read DNA sequencing resolves a rare case of alloimmune hemolysis mimicking autoimmune hemolysis.

Transfusion
2025

An Unusual Presentation of IgM Myeloma.

The Journal of the Association of Physicians of India
2025

Inborn Errors of Immunity in Pediatric Hematology and Oncology: Diagnostic Principles for Clinical Practice.

Journal of clinical medicine
2025

[Detection and Transfusion Strategy of Mimicking Antibodies].

Zhongguo shi yan xue ye xue za zhi
2025

[Efficacy and Safety of Zanubrutinib in the Treatment of Autoimmune Cytopenia Secondary to Indolent B-Cell Lymphoma].

Zhongguo shi yan xue ye xue za zhi
2025

Suspected Sildenafil-Induced Immune Hemolytic Anemia Precipitating Acute Kidney Injury Requiring Hemodialysis.

Cureus
2025

A Case Report of a 14-year-old Boy with Mixed-type Autoimmune Hemolytic Anemia.

Annals of African medicine
2024

Autoimmune Hemolytic Anemia From Tofacitinib Use in a Patient With Ulcerative Colitis.

ACG case reports journal
2025

[Future directions in the management of warm autoimmune hemolytic anemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2025

Effectiveness of sirolimus for early on-set autoimmune cytopenias of autoimmune lymphoproliferative immunodeficiencies.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2025

A Rare Acute Complication Early After Glucocorticoid Administration in a Case of Autoimmune Haemolytic Anemia (AIHA): A Case Report.

Cureus
2025

Acute Hemolytic Anemia and Immune Thrombocytopenia: A Rare Case of Parvovirus B19-Induced Evans Syndrome.

Cureus
2025

Mixed-type autoimmune hemolytic anaemia complicated by acute cerebral infarction: a case report.

Frontiers in medicine
2025

Autoimmune Hemolytic Anemia in a Patient with Generalized Pustular Psoriasis Treated with Brodalumab: A Case Report.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi
2025

Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing.

Signal transduction and targeted therapy
2025

Fatal Cytokine Collision: HLH-AIHA in Advanced AIDS-Case Report and Literature Review.

Reports (MDPI)
2025

FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia.

Antibodies (Basel, Switzerland)
2025

Severe hemolysis flare of refractory autoimmune hemolytic anemia with positive complement component C3d responsive to Iptacopan with cyclophosphamide and prednisone: a case report.

Hematology (Amsterdam, Netherlands)
2025

Evans Syndrome: Analysis of 1255 Adult Cases in US Hospitals, Revealing Demographics, Associations, and Outcomes.

International journal of hematology-oncology and stem cell research
2025

Severe Warm Autoimmune Hemolytic Anemia With Anti-PO Antibody Positivity: A Diagnostic Dilemma in a Resource-Limited Setting.

Cureus
2025

From Yellow Cumulus to Pregnancy in Autoimmune Hemolytic Anemia Following Bilirubin Reduction: A Case Report.

Cureus
2025

[A Case of Breast Cancer with Bone Marrow Metastasis in a Patient with a History of Systemic Lupus Erythematosus and Autoimmune Hemolytic Anemia].

Gan to kagaku ryoho. Cancer &amp; chemotherapy
2025

Successful Dostarlimab Rechallenge Following Pembrolizumab-Induced Autoimmune Hemolytic Anemia: A Case Report.

Clinical case reports
2025

Beneath the surface in autoimmune hemolytic anemia: pathogenetic networks, therapeutic advancements and open questions.

Frontiers in immunology
2025

Eosinophilic mesenteric vasculitis presenting as inflammatory bowel disease.

JPGN reports
2025

Targeting the neonatal Fc receptor (FcRn) in hematologic conditions with a focus on warm autoimmune hemolytic anemia.

Blood reviews
2025

Babesiosis-induced warm autoimmune hemolytic anemia, from infection to hemolysis: a case report.

Journal of medical case reports
2025

A Case of Primary Cold Agglutinin-Mediated Hemolytic Anemia Successfully Treated with Steroids.

Cureus
2025

Case Report: Successful treatment of spondyloenchondrodysplasia with immune dysregulation using tofacitinib and ruxolitinib: a report of two pediatric cases.

Frontiers in pharmacology
2025

Autoimmune Hemolytic Anemia as an Initial Manifestation of Splenic Marginal Zone Lymphoma.

Cureus
2025

The Clinical Significance of Warm Autoantibodies during Pregnancy.

Transfusion medicine (Oxford, England)
2025

Exploring patients' experiences with wAIHA and the content validity of the FACIT-fatigue: a qualitative interview study.

Orphanet journal of rare diseases
2025

[Treatment strategies for autoimmune hemolytic anemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2025

A Case of Severe Anemia in Pregnancy Treated With Traditional Chinese Medicine.

Clinical case reports
2025

A Case of Cold Agglutinin Disease With Transformation to High-Grade Lymphoma During Sutimlimab Treatment.

Cureus
2025

Content validity and meaningful change for the FACIT-Fatigue scale in warm autoimmune hemolytic anemia: results from qualitative interview studies with patients.

Journal of patient-reported outcomes
2025

Evans syndrome revisited.

Blood reviews
2025

A Rare Case of Cold Antibody-Mediated Autoimmune Haemolytic Anaemia in Early Systemic Lupus Erythematosus.

Cureus
2025

A Hyperacute Presentation of Small Cell, Non-Nodal Mantle Cell Lymphoma.

Case reports in hematology
2025

Rare case of warm IgM autoimmune hemolytic anemia.

Transfusion
2025

ABO-Mismatch Hematopoietic Stem Cell Transplantation with Pre-existing Red Cell Alloantibody Resembling a Case of Post-transplant Autoimmune Hemolytic Anemia.

Indian journal of hematology &amp; blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
2025

Cold Agglutinin Syndrome Secondary to Mycoplasma pneumoniae Infection in Adults: Results From a Large French Observational Study (MyCOLD Study).

American journal of hematology
2025

Immune hemolytic anemia associated with the use of immune checkpoint inhibitors: a scoping review.

Frontiers in immunology
2025

Advancements in Autoimmune Hemolytic Anemia (AIHA) treatment: Exploring emerging therapies.

Leukemia research
2025

Primary antiphospholipid syndrome in pediatrics: New criteria, new opportunities.

Lupus
2025

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

American journal of hematology
2025

A case of autoimmune hemolytic anemia with cold agglutinin disease post-operation for recurrent ovarian cancer.

International cancer conference journal
2025

Whole Exome Sequencing of Adult Patients With Evans Syndrome Reveals Pathogenic Variants Associated With Autoimmunity.

American journal of hematology
2025

Development and consequences of red blood cell autoantibodies: warm autoimmune hemolytic anemia.

Current opinion in immunology
2025

A Less Common but Lethal Encounter: Mixed Autoimmune Hemolytic Anemia Unmasking Angioimmunoblastic T-cell Lymphoma.

Cureus
2025

Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

Hematology/oncology clinics of North America
2025

Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications.

Annals of hematology
2025

Exploration of B- and T-Cell Receptor Repertoires Reveals Distinct Mechanisms in Pure Red Cell Aplasia, Autoimmune Hemolytic Anemia, and Aplastic Anemia.

Acta haematologica
2025

Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016-2023.

PloS one
2025

Cold Agglutinin Autoimmune Hemolytic Anemia Revealing Undiagnosed Diffuse Large B-cell Lymphoma Following COVID-19 Vaccination.

Cureus
2025

Prediction of thrombotic events in patients with autoimmune hemolytic anemia: a multicenter retrospective observational study.

Journal of thrombosis and thrombolysis
2025

Splenectomy following rituximab and cyclophosphamide for severe autoimmune hemolytic anemia in pregnancy.

Hematology (Amsterdam, Netherlands)
2025

Autoimmune Complications of Lymphoproliferative Diseases.

Hematological oncology
2025

Long-Term Outcomes of Rituximab Therapy in Autoimmune Hemolytic Anemia: A Systematic Review and Meta-Analysis.

Cureus
2025

Evans Syndrome and COVID-19 Infection or Vaccination: A Systematic Review of Case Reports.

Journal of hematology
2025

BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy.

The New England journal of medicine
2025

A Rare Case of Warm Autoimmune Hemolytic Anemia With Intravascular Hemolysis: A Case Report.

Cureus
2025

A Rare Case of Autoimmune Hemolytic Anemia and Suspected Acute Hemorrhagic Disseminated Encephalomyelitis Following Recent Vaccination.

Cureus
2025

Anesthetic Management During Total Abdominal Hysterectomy in a Patient With Cold Agglutinin Disease: A Case Report.

Cureus
2025

Pegcetacoplan for the treatment of warm autoimmune hemolytic anemia: a case report.

Blood cells, molecules &amp; diseases
2024

Case Report: Acute hepatitis A virus infection presenting with direct antiglobulin test-negative autoimmune hemolytic anemia and α-thalassemia trait.

F1000Research
2025

Cohabitating in the City: A Case of Hemolytic Anemia in a Patient Coinfected With Babesiosis, Lyme Disease, and Mononucleosis.

Cureus
2025

[Efficacy and safety of zanubrutinib in treating refractory/relapsed warm autoimmune hemolytic anemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
2025

Construction of a predictive model for relapse of primary autoimmune hemolytic anemia: a retrospective cohort study.

Annals of medicine
2025

Retrospective analysis of 26 children with severe autoimmune hemolytic anemia treated with transfusions of red blood cells.

Pediatric hematology and oncology
2025

Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes.

American journal of hematology
2025

Autoimmune hemolytic anemia due to biphasic Donath-Landsteiner hemolysin: a diagnostic challenge.

Archivos argentinos de pediatria
2025

Autoimmune Hemolytic Anemia Following Kidney Transplant: The Role of Tacrolimus and Transition to Everolimus in a Pediatric Case.

Pediatric transplantation
2025

A middle-aged woman with the initial symptom of acrocyanosis diagnosed with cold agglutinin disease: A case report.

SAGE open medical case reports
2025

A Room for Long-Lived Plasma Cell Contribution in Immune Cytopenias?

Cancers
2025

Vesiculation as potential novel pathogenic mechanism in autoimmune hemolytic anemia.

Transfusion
2025

Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes.

Clinical immunology (Orlando, Fla.)
2025

Use of real-world data for the development and the follow-up of drugs in rare diseases. The example of immune thrombocytopenia and autoimmune hemolytic anemia.

La Revue de medecine interne
2025

Severe Malaria Infection Concurrent With Autoimmune Hemolytic Anemia and Acute Cytomegalovirus Infection: A Case Report.

Cureus
2025

Prevalence of systemic lupus erythematosus in autoimmune hemolytic anemia patients based on coombs test results.

European journal of medical research
2025

Eosinophilic Granulomatous Polyangiitis with Autoimmune Hemolytic Anemia: A Case Report and Review of the Literature.

Journal of asthma and allergy
2025

A Germline Heterozygous Dominant Negative IKZF2 Variant Causing Syndromic Primary Immune Regulatory Disorder and ICHAD.

Journal of clinical immunology
2025

Immune checkpoint Inhibitor-Induced Autoimmune hemolytic anemia in endometrial cancer.

Gynecologic oncology reports
2025

Recurrent Acquired Angioedema as a Heralding Sign of Splenic Marginal Zone Lymphoma Recurrence.

Cureus
2025

Severe autoimmune hemolytic anemia associated with glucose-6-phosphate dehydrogenase deficiency as a complication of nivolumab treatment: A case report.

International journal of clinical pharmacology and therapeutics
2025

Efficacy of tocilizumab monotherapy for autoimmune hemolytic anemia associated with idiopathic multicentric Castleman disease: a case-based review.

Rheumatology international
2025

A Case of Systemic Lupus Erythematosus Complicated by Secondary Evans Syndrome.

Cureus
2025

Spinal Anesthesia in a Patient With Cold Agglutinin Disease Presenting for Total Knee Arthroplasty in a Community Hospital Setting.

Cureus
Ver todos os 2.422 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Anemia hemolítica autoimune.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Anemia hemolítica autoimune

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies.
    Blood reviews· 2026· PMID 41850974mais citado
  2. Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials.
    Lupus science &amp; medicine· 2026· PMID 41850755mais citado
  3. Autoimmune hemolytic anemia: New frontiers in diagnosis and therapy.
    Blood reviews· 2026· PMID 41813558mais citado
  4. Warm autoimmune hemolytic anemia in adults in Latin America: A scoping review.
    Hematology, transfusion and cell therapy· 2026· PMID 41797180mais citado
  5. Therapeutic plasma exchange as a rescue and bridging therapy for life-threatening autoimmune hemolytic anemia associated with angioimmunoblastic T-cell lymphoma.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis· 2026· PMID 41713183mais citado
  6. Delayed-Onset Autoimmune Hemolytic Anemia in Advanced HIV With Cerebral Toxoplasmosis.
    Cureus· 2026· PMID 41993768recente
  7. [Rapid response to linperlisib in relapsed/refractory autoimmune hemolytic anemia: a case report].
    Zhonghua Xue Ye Xue Za Zhi· 2026· PMID 41991318recente
  8. [Treatment practice and outcomes in 125 patients with autoimmune hemolytic anemia: a single-center retrospective analysis].
    Zhonghua Xue Ye Xue Za Zhi· 2026· PMID 41991308recente
  9. Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimab.
    Front Immunol· 2026· PMID 41983131recente
  10. Zieve's Syndrome in a Patient With Alcohol Use Disorder and Alcohol-Associated Cirrhosis: A Case Report and Review of the Literature.
    Cureus· 2026· PMID 41982369recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98375(Orphanet)
  2. OMIM OMIM:205700(OMIM)
  3. MONDO:0020108(MONDO)
  4. GARD:5870(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q28814(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Anemia hemolítica autoimune
Compêndio · Raras BR

Anemia hemolítica autoimune

ORPHA:98375 · MONDO:0020108
Prevalência
1-5 / 10 000
Herança
Multigenic/multifactorial
CID-11
Ensaios
34 ativos
Início
All ages
Prevalência
11.0 (Denmark)
MedGen
UMLS
C0002880
Repurposing
11 candidatos
azacitidineDNA methyltransferase inhibitor
cyanocobalaminmethylmalonyl CoA mutase stimulant|vitamin B
decitabineglucocorticoid receptor agonist
+8 outros
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades